Rankings
▼
Calendar
ARGX Q2 2023 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$468M
+320.5% YoY
Gross Profit
$107M
22.9% margin
Operating Income
-$189M
-40.3% margin
Net Income
-$113M
-24.1% margin
EPS (Diluted)
$-2.03
QoQ Revenue Growth
+281.5%
Cash Flow
Operating Cash Flow
-$258M
Free Cash Flow
-$262M
Stock-Based Comp.
$94M
Balance Sheet
Total Assets
$3.2B
Total Liabilities
$336M
Stockholders' Equity
$2.9B
Cash & Equivalents
$1.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$468M
$111M
+320.5%
Gross Profit
$107M
-$169M
+163.6%
Operating Income
-$189M
-$379M
+50.3%
Net Income
-$113M
-$416M
+72.9%
Geographic Segments
United States
$441M
90%
Japan
$24M
5%
EMEA
$23M
5%
← FY 2023
All Quarters
Q3 2023 →